Clinical Trial Update: qEEG Brain Signature of Depression & Neuromodulation-induced Recovery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating qEEG brain signatures of major depressive disorder and recovery induced by neuromodulation, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Major Depressive Diorder | Phase 1 | Status: RECRUITING